DOI · e01.org

Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target

Pramod Kumar Maurya, Alok Mishra, Birendra Singh Yadav, Swati Singh, Prashant Kumar, Amit Chaudhary, Shweta Srivastava, Suriya Narayan Murugesan, Ashutosh Mani · Journal of Cancer · 2017

  • DOI 10.7150/jca.17689
  • Publisher Ivyspring International Publisher
  • Type review
  • Issued 2017

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · review · 2017

Abstract

The Y-box binding protein (YB-1) is known to be a multifunctional transcription and translation factor during expression of several proteins.It is a vital oncoprotein that regulates cancer cell progression and proliferation.YB-1 is over-expressed in various human cancers such as breast cancer, colon cancer, lung cancer, gastric cancer, oesophageal cancer and glioblastoma.Nuclear expression of YB-1 is found to be associated with multidrug resistance and cancer cell progression.YB-1 is reported to regulate many cellular signalling pathways in different types of cancer proliferation.Knowledge about nuclear localization and nuclear level expression of YB-1 in different cancers has been correlated with prospective prognosis of cancer.This review discusses the prospects of YB-1 as a potential biomarker as well as therapeutic target in lieu of their role during cancer progression and multidrug resistance.

Open the resolved locator · 10.7150/jca.17689

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:15 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v08p1900.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.